Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
QAA is the FDA product code for Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens, a class II device type, regulated under 21 CFR 866.3376. FDA's definition for this code reads: "A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QAA
- Device name
- Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
- FDA definition
- A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.
- Regulation
- 21 CFR 866.3376
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code QAA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
Applicants with the most clearances
Product code QAA| Applicant | Clearances |
|---|---|
| Dxna, LLC | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
